Attendance at a Transitional Liver Clinic May Be Associated with Reduced Readmissions for Patients with Liver Disease.
Attendance at a Transitional Liver Clinic May Be Associated with Reduced Readmissions for Patients with Liver Disease.
复制标题
DOI:
10.1016/j.amjmed.2021.09.016
复制
发表时间:
2022-03
期刊:
影响因子:
--
通讯作者:
Orman ES
中科院分区:
文献类型:
--
作者:
Yoder L;Mladenovic A;Pike F;Vuppalanchi R;Hanson H;Corbito L;Desai AP;Chalasani N;Orman ES
Patients with liver disease have high rates of early hospital readmission, but there are no studies of effective, scalable interventions to reduce this risk. In this study, we examined the impact of a Physician Assistant (PA)-led post-discharge Transitional Liver Clinic (TLC) on hospital readmissions. We performed a cohort study of all adults seen by a hepatologist during admission to a tertiary care center in 2019 (excluding transplant patients). We compared those who attended the TLC with those who did not with respect to 30-day readmission and mortality. Propensity score-adjusted modeling was used to control for confounding. Of 498 patients, 98 were seen in the TLC. 35% had alcoholic liver disease, and 58% had cirrhosis. Attendees were similar to non-attendees with respect to demographics, liver disease characteristics and severity, comorbidities, and discharge disposition. 30-day cumulative incidence of readmissions was 12% in TLC attendees, compared to 22% in non-attendees (p=0.02), while 30-day mortality was similar (2.0% vs. 4.3%; p=0.29). In a model using propensity score adjustment, TLC attendance remained associated with reduced readmissions (SHR 0.52; 95% CI, 0.27–0.997; p=0.049). The effect of TLC was greater in women compared to men (p=0.07) and in those without chronic kidney disease (p=0.02), but there were no differences across other subgroups. Patients with liver disease seen in a PA-led TLC may have a significant reduction in the 30-day readmission rate. Randomized trials are needed to establish the efficacy of PA-led post-discharge transitional care for this population.
登录
查看更多内容
DOI:
10.1016/j.cgh.2019.04.048
发表时间:
2020-02
期刊:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子:
--
作者:
通讯作者:
--
影响因子:
2.9
作者:
Garg, Sushil K.;Sarvepalli, Shashank;Leise, Michael D.
通讯作者:
Leise, Michael D.
影响因子:
3.5
作者:
Mitchell SG;Schwartz RP;Alvanzo AA;Weisman MS;Kyle TL;Turrigiano EM;Gibson ML;Perez L;McClure EA;Clingerman S;Froias A;Shandera DR;Walker R;Babcock DL;Bailey GL;Miele GM;Kunkel LE;Norton M;Stitzer ML
通讯作者:
Stitzer ML
影响因子:
25.7
作者:
Morando, Filippo;Maresio, Giulio;Angeli, Paolo
通讯作者:
Angeli, Paolo
影响因子:
9.8
作者:
Volk, Michael L.;Tocco, Rachel S.;Bazick, Jessica;Rakoski, Mina O.;Lok, Anna S.
通讯作者:
Lok, Anna S.